These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New antibiotics for skin and skin-structure infections. Tacconelli E; Kern WV Lancet Infect Dis; 2014 Aug; 14(8):659-661. PubMed ID: 24909500 [No Abstract] [Full Text] [Related]
5. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. Moran GJ; Fang E; Corey GR; Das AF; De Anda C; Prokocimer P Lancet Infect Dis; 2014 Aug; 14(8):696-705. PubMed ID: 24909499 [TBL] [Abstract][Full Text] [Related]
6. A closer inspection of tedizolid. Taylor J Lancet Infect Dis; 2015 Apr; 15(4):374. PubMed ID: 25809887 [No Abstract] [Full Text] [Related]
7. Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections. Hardalo C; Lodise TP; Bidell M; Flanagan S; De Anda C; Anuskiewicz S; Prokocimer P Expert Opin Drug Saf; 2018 Apr; 17(4):359-367. PubMed ID: 29528251 [TBL] [Abstract][Full Text] [Related]
8. Two new drugs for skin and skin structure infections. Med Lett Drugs Ther; 2014 Aug; 56(1449):73-5. PubMed ID: 25118799 [No Abstract] [Full Text] [Related]
9. [Linezolide--an antibiotic with new action mechanism]. Hedström SA Lakartidningen; 2002 Mar; 99(11):1201-2, 1205-8. PubMed ID: 11985017 [No Abstract] [Full Text] [Related]